Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 20.64
(5.84%)
CNY 20.64
(5.84%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 713.62 Million CNY | -11.26% |
| 2022 | 804.19 Million CNY | 162.27% |
| 2021 | 306.62 Million CNY | 225.55% |
| 2020 | 94.18 Million CNY | 992.68% |
| 2019 | 8.61 Million CNY | -13.64% |
| 2018 | 9.98 Million CNY | -12.0% |
| 2017 | 11.34 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 585.78 Million CNY | -11.69% |
| 2024 Q1 | 655.04 Million CNY | -8.96% |
| 2024 Q2 | 663.32 Million CNY | 4.71% |
| 2023 FY | 713.62 Million CNY | -11.26% |
| 2023 Q2 | 907.5 Million CNY | 5.67% |
| 2023 Q1 | 858.81 Million CNY | 6.79% |
| 2023 Q4 | 713.62 Million CNY | 3.82% |
| 2023 Q3 | 687.4 Million CNY | -24.25% |
| 2022 Q2 | 402.31 Million CNY | 13.96% |
| 2022 FY | 804.19 Million CNY | 162.27% |
| 2022 Q4 | 804.19 Million CNY | 37.84% |
| 2022 Q3 | 583.43 Million CNY | 45.02% |
| 2022 Q1 | 353.03 Million CNY | 15.14% |
| 2021 FY | 306.62 Million CNY | 225.55% |
| 2021 Q2 | 167.19 Million CNY | 0.56% |
| 2021 Q3 | 213.88 Million CNY | 27.93% |
| 2021 Q4 | 306.62 Million CNY | 43.36% |
| 2021 Q1 | 166.25 Million CNY | 76.52% |
| 2020 Q3 | 43.34 Million CNY | 55.59% |
| 2020 FY | 94.18 Million CNY | 992.68% |
| 2020 Q2 | 27.85 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 94.18 Million CNY | 117.29% |
| 2019 Q4 | 8.61 Million CNY | 0.0% |
| 2019 FY | 8.61 Million CNY | -13.64% |
| 2018 FY | 9.98 Million CNY | -12.0% |
| 2017 FY | 11.34 Million CNY | 0.0% |